 |
 |
The William B. Abrams Award in Geriatric Clinical PharmacologyThe William B. Abrams Award in Geriatric Clinical Pharmacology was established with support from the Merck Company Foundation in 1996 to honor a young investigator in geriatric clinical pharmacology for outstanding contributions to the field.Dr. Abrams, a Past President of ASCPT, had a long and illustrious career in the pharmaceutical industry, mostly at the Merck Research Laboratories. Among his many accomplishments in geriatric clinical pharmacology, he was the founding Co-Editor of the Merck Manual of Geriatrics, created the Scientific Section on Geriatric Clinical Pharmacology of ASCPT, and developed and funded post-doctoral training programs in geriatric clinical pharmacology. Dr. Abrams' objective in establishing this award was to encourage more young scientists to enter the field of geriatric clinical pharmacology by recognizing their accomplishments at the Society's Annual Meeting.
EligibilityA nominee must be a young investigator in geriatrics who is actively involved in high-quality teaching and research in geriatric clinical pharmacology. The nominee must not be more than 45 years of age as of March 1 of the year in which the award is presented.
Prize and PresentationThe William B. Abrams Award in Geriatric Clinical Pharmacology is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society. This award is funded on behalf of Dr. Abrams through the generosity of The Merck Company Foundation.
Previous Recipients
For more information about the William B. Abrams Award in Geriatric Clinical Pharmacology, please contact ASCPT at (703) 836-6981 or meetings@ascpt.org.
|
